Signum Biosciences' Series A - II Round

Signum Biosciences raised a round of funding on July 24, 2007.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Series A - II Round: